Is Messenger RNA Patent-Eligible?
Amid ongoing patent disputes over the mRNA platform, a significant scientific question remains unanswered: whether mRNA itself even is patent eligible.
biontech
-
Read more: Is Messenger RNA Patent-Eligible? -
Read more: Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.
-
Read more: Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity? Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?
If pharma giants truly are committed to addressing vaccine inequity, just building manufacturing capacity in Africa might not be enough.
-
Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.
-
Read more: Challenges in COVID-19 Vaccine Rollout: Lessons from the UK Challenges in COVID-19 Vaccine Rollout: Lessons from the UK
The U.S. can and should cautiously assess the U.K.’s vaccination strategy to avoid challenges that may impede its ability to control the virus.
